Saratoga Investment Corp. — Form 8-K Summary
Business context and reporting period
Filed October 8, 2026, this report describes an amendment to the credit facility of Saratoga Investment Funding II LLC (SIF II), Saratoga Investment Corp.’s wholly owned financing subsidiary. The filing reports a financing transaction, not quarterly or annual operating results.
Financial and facility terms
- The Valley Credit Facility’s borrowing commitment increased from $85.0 million to $110.0 million. The filing does not state amounts drawn, remaining availability, or the facility’s interest rate.
- For the first two years after closing, SIF II may request one or more commitment increases up to $135.0 million, subject to conditions and a customary fee. This is an option, not a stated increase already made.
- The advance rate for Unitranche Loans is capped at 70%.
Material changes and risks
- The permitted healthcare-industry concentration increased from 25.0% to 35.0% of Aggregate ECA Value.
- The permitted concentration in loans to the three largest obligors increased from 30.0% to 35.0% of Aggregate ECA Value.
- The definition of “Key Person” was amended to replace Henri Steenkamp with Christine Ramdihal.
- Higher concentration limits may allow greater exposure to particular industries and borrowers. The filing does not quantify the portfolio’s current concentrations or explain the effects on earnings, cash flow, margins, or liquidity.
Investor facts to verify
- Review Exhibit 10.1 for the amendment’s full terms, conditions, and fees.
- Confirm actual facility borrowings, unused capacity, and any subsequent commitment increase.
- Check current healthcare and largest-obligor concentrations against the revised limits.
- Assess the 70% Unitranche Loan advance-rate cap and the amendment’s effect on collateral availability.